Abstract:Background/Aims: In the European Union Euricterus Project on (sub)Icterus proforma, the history and physical examination items were to be used for the physician's working diagnosis (PWD) and ,among others, for the development of the real life data electronic diagnostic tool, Trial(C). Trial(C) delivers diagnosis probabilities based on Bayes' Theorem (B), completed by Trial Algorithm (TA). We wanted to compare the diagnostic accuracies (PWD and Trial(C) probabilities as a percentage of the final diagnosis (FD) in a patient population) in 3 Dutch databases.Methodology: The inclusion criteria for both Euricterus and Trial(C) were age greater than or equal to 16 and bilirubin greater than or equal to 20 mmol/l. Euricterus data gathering took place at the bedside on a proforma with (among other questions) 79 questions on, history and physical examination as well as the diagnosis levels for the PWD (1 alternative possible) and FD (17 disease categories, dc). Trial(C) was developed on the data of 7,104 Euricterus patients and its data-entry Demo(C) has the same questions. It calculates the probability of each diagnosis of the 17 dc as a percentage, as each significant finding is encountered (BO, Bayesian Overall). It can simultaneously calculate the resemblance of the patient's signs and symptoms to each disease concomitantly (BV, Bayesian Vertical), and to any subset of a disease. Any probability is further tested for compatibility using TA, a subset of BV, delivering TA-PWD, TA-BO and TA-BV. The Trial(C) test patients came from 3 databases: a Euricterus Dutch Patients Random Sample EDRS (n=184, internal database) and 2 independent databases. prospective P (n=80) and retrospective R (n=152), totalling 416 patients.Results: The accuracies of PWD and Trial(C) showed no differences between the databases, and the results are therefore pooled (n=416). With testing on the highest probability found, the PWD accuracy was 78%, TA-PWD 81%, TA-BO 74% and TA-BV 72%. The true FD's were mentioned (at any probability) in the PWD in 86%, TA-PWD in 92%, TA-BO in 94% and TA-BV in 91% of the patients. Testing only patients whose FD was ''certain'' or whose data were without omissions did not improve accuracy. Testing on probability >95% improved BO and BV accuracy, but not TA-BO or TA-BV.Conclusions: The Physician's Working Diagnosis accuracy was approximately 80% and did not greatly improve after TA. The Trial(C) TA-BO and TA-BV accuracies were only slightly less than, the PWD. For well-trained physicians, Trial(C) strengthens the physician's judgment, and for those less trained (or those to be trained), it delivers a (sub)icterus diagnostic disease probability at nearly consultant level.

Primary Biliary Cirrhosis: an Electronic Diagnostic Tool Trial Based on Symptoms, (past) History and Signs Only, Using the European Database Euricterus. the Euricterus PMG.

Clinical Analysis of Primary Biliary Cirrhosis: a Report of 31 Cases

A Serum Metabolomic Analysis for Diagnosis and Biomarker Discovery of Primary Biliary Cirrhosis and Autoimmune Hepatitis.

Physician's Working Diagnosis Compared to the Euricterus Real Life Data Diagnostic Tool Trial in Three Jaundice Databases: Euricterus Dutch, Independent Prospective and Independent Retrospective.

Insight into the natural history of primary biliary cirrhosis: A systemic review of data from placebo-controlled clinical trials.

A case of primary biliary cholangitis – diagnostic and treatment approaches

Primary biliary cirrhosis:an analysis of 76 cases

Non-Invasive Assessment of Liver Fibrosis Progression and Prognosis in Primary Biliary Cholangitis

[Clinical and Pathological Characteristics of Primary Biliary Cirrhosis].

[Primary biliary cholangitis. Experience in 179 patients]

Clinical Characteristics of Primary Biliary Cirrhosis: a Retrospective Analysis of 101 Cases

Histological diagnosis of primary biliary cholangitis in one patient without cholestasis alterations: a case report that escaped guidelines

Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool

[Clinical Analysis of Primary Biliary Cirrhosis: a Report of 42 Cases].

Survival Probabilities Of Pugh-Child-Pbc Classified Patients In The Euricterus Primary Biliary Cirrhosis Population, Based On The Mayo Clinic Prognostic Model

The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature

Clinical characteristics of patients with primary biliary cirrhosis

Evaluation of patients with positive anti-mitochondiral antibody and normal alkaline phosphatase levels for primary biliary cholangitis

Identifying Patients With Primary Biliary Cholangitis and Cirrhosis Using Administrative Data in a National Cohort

S72 Diagnostic Value of Anti-Mitochondrial Antibodies (AMA), Anti-M2, Anti-sp100, and Anti-gp210 in Primary Biliary Cholangitis (PBC)

[Primary sclerosing cholangitis-Diagnosis and treatment 2024]